title: Lipid-lowering agents in chronic kidney disease: do fibrates have a role?
authors.forename: Yuli
authors.initials: Y
authors.lastname: Huang
authors.forename: Yunzhao
authors.initials: Y
authors.lastname: Hu
mesh_terms: D006348:Cardiac Surgical Procedures; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000628:therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000628:therapy*
chemical_list: D002317:Cardiovascular Agents
references.citation: Nat Rev Cardiol. 2013 May;10(5):261-73
references.pmid: 23419899
references.citation: Ann Intern Med. 2012 Aug 21;157(4):263-75
references.pmid: 22910937
references.citation: Lancet. 2005 Nov 26;366(9500):1849-61
references.pmid: 16310551
references.citation: Diabetes Care. 2012 Feb;35(2):218-25
references.pmid: 22210576
references.citation: Nat Rev Endocrinol. 2011 Mar;7(3):130-1
references.pmid: 21301489
references.citation: Diabetologia. 2011 Feb;54(2):280-90
references.pmid: 21052978
references.citation: Clin Exp Nephrol. 2012 Aug;16(4):522-9
references.pmid: 22722878
references.citation: Ann Intern Med. 2012 Aug 21;157(4):251-62
references.pmid: 22910936
references.citation: Pharmacol Res. 2013 Jun;72:35-44
references.pmid: 23542730
references.citation: J Am Coll Cardiol. 2012 Nov 13;60(20):2061-71
references.pmid: 23083786
references.citation: Diabetes Care. 2012 May;35(5):1008-14
references.pmid: 22432114
references.citation: J Am Coll Cardiol. 2012 Nov 13;60(20):2072-3
references.pmid: 23083778